Clinical Trial

Hepatocellular Carcinoma associated with NAFLD in South Texas

Study Status:

Contact Information:

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose

In this study we aim (1) to determine the tumor genomic landscape of NASH-associated Hepatocellular Carcinomas in patients in South Texas and, (2) to detect selected somatic mutations in plasma cfDNA in patients with NASH-associated Hepatocellular Carcinoma, using a custom-designed targeted sequencing panel.


Principal Investigator Jose Almeda, MD
Type of Trial Prospective